Cost-effectiveness analysis of patent foramen ovale closure with Amplatzer plus medical therapy compared to medical therapy in patients with a history of stroke in France.

Fiche publication

Date publication

novembre 2021

Journal

Journal of cardiology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LORGIS Luc

Tous les auteurs :
Allou A, Baschet L, Sabourin C, Montalscot G, Lorgis L, Iriart X

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34772575

Résumé

A patent foramen ovale (PFO) is formed when the ovale foramen does not close spontaneously or re-opens leaving the right and left atrium connected. The present study was conducted to analyze the cost-effectiveness of PFO closure with Amplatzer device plus medical therapy (MT) compared to MT alone in the French reimbursement system for PFO patients with a prior history of stroke, using the RESPECT study data.